Allogene Therapeutics, Inc. (ALLO) Capital expenditures 2018–2025
Allogene Therapeutics, Inc. (ALLO) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$386,000FY2025 · since FY2018: $3.2M → $386,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $386,000 | -44.4% |
| FY2024 | $694,000 | -54.2% |
| FY2023 | $1.5M | -70.8% |
| FY2022 | $5.2M | -75.8% |
| FY2021 | $21.4M | -67.5% |
| FY2020 | $66.0M | +29.9% |
| FY2019 | $50.8M | +1470.5% |
| FY2018 | $3.2M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice